{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:05:52Z","timestamp":1789167952646,"version":"build-2803163510"},"reference-count":149,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clindermatol.2021.05.006","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:28:09Z","timestamp":1620944889000},"page":"784-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Cannabis and the skin"],"prefix":"10.1016","volume":"39","author":[{"given":"Kimberly","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Campbell","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Grant-Kels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2021.05.006_bib0001","first-page":"1273","article-title":"Knowledge, attitudes, and perceptions of cannabinoids in the dermatology community","volume":"17","author":"Robinson","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0002","doi-asserted-by":"crossref","DOI":"10.5070\/D3246040706","article-title":"Cannabinoids in dermatology: a scoping review","volume":"24","author":"Eagleston","year":"2018","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0003","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"36","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0005","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/jid.2015.45","article-title":"Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death","volume":"135","author":"Armstrong","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0006","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/all.12183","article-title":"Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors","volume":"68","author":"Gaffal","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0007","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.lfs.2015.12.053","article-title":"Ligands for cannabinoid receptors, promising anticancer agents","volume":"146","author":"Nikan","year":"2016","journal-title":"Life Sci"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0008","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mc.22257","article-title":"Arachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: role of cyclooxygenase-2 and novel J-series prostamides","volume":"55","author":"Soliman","year":"2016","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0009","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1096\/fj.06-6638fje","article-title":"Cannabinoid receptors as novel targets for the treatment of melanoma","volume":"20","author":"Bl\u00e1zquez","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0010","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1172\/JCI64628","article-title":"Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes","volume":"124","author":"Ol\u00e1h","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0011","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1600-0625.2009.00923.x","article-title":"Cannabinoid system in the skin - possible target for future therapies in dermatology","volume":"18","author":"Kupczyk","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jdermsci.2006.10.009","article-title":"Cannabinoids inhibit human keratinocyte proliferation through a non-CB1\/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis","volume":"45","author":"Wilkinson","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0013","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jdermsci.2015.11.005","article-title":"The cross-talk between electrophiles, antioxidant defence and the endocannabinoid system in fibroblasts and keratinocytes after UVA and UVB irradiation","volume":"81","author":"G\u0119gotek","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0014","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI200316116","article-title":"Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors","volume":"111","author":"Casanova","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0015","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/mc.22429","article-title":"Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: receptor-independent endocannabinoid signaling","volume":"55","author":"Soliman","year":"2016","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0016","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-07-6594","article-title":"The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development","volume":"68","author":"Zheng","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0017","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.lfs.2012.09.025","article-title":"Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth","volume":"92","author":"Van Dross","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0018","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1074\/jbc.M111.314880","article-title":"Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor","volume":"287","author":"Pucci","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0019","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0898-6568(03)00036-6","article-title":"D\u00edaz-Laviada I. Activation of phosphoinositide 3-kinase\/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction","volume":"15","author":"S\u00e1nchez","year":"2003","journal-title":"Cell Signal"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jss.2018.08.055","article-title":"Cannabinoids as a potential new and novel treatment for melanoma: a pilot study in a murine model","volume":"235","author":"Simmerman","year":"2019","journal-title":"J Surg Res"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0021","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lfs.2015.04.003","article-title":"Differential role of cannabinoids in the pathogenesis of skin cancer","volume":"138","author":"Glodde","year":"2015","journal-title":"Life Sci"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0022","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.tiv.2017.01.018","article-title":"Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells","volume":"40","author":"Carpi","year":"2017","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0023","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mcn.2014.12.001","article-title":"Regional effects of endocannabinoid, BDNF and FGF receptor signalling on neuroblast motility and guidance along the rostral migratory stream","volume":"64","author":"Zhou","year":"2015","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0024","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1634\/theoncologist.2018-0383","article-title":"Cannabis impacts tumor response rate to nivolumab in patients with advanced malignancies","volume":"24","author":"Taha","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2009.06.004","article-title":"The CB1\/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro","volume":"616","author":"Luca","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0026","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/1947601912466556","article-title":"Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma\u2013associated herpesvirus-infected endothelium","volume":"3","author":"Maor","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0027","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1158\/0008-5472.CAN-07-0960","article-title":"Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation","volume":"67","author":"Zhang","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0028","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.7717\/peerj.40","article-title":"A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ","volume":"1","author":"Ramot","year":"2013","journal-title":"PeerJ"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0029","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/molecules25030652","article-title":"Cannabinoids in the pathophysiology of skin inflammation","volume":"25","author":"Scheau","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0030","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/09546634.2019.1675854","article-title":"The potential role of cannabinoids in dermatology","volume":"31","author":"Sheriff","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0031","series-title":"inventors; AXIM Biotechnologies, Inc, assignee","author":"Changoer","year":"2018"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0032","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jdermsci.2005.01.007","article-title":"Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin","volume":"38","author":"St\u00e4nder","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0033","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/jid.2012.118","article-title":"Endocannabinoids regulate growth and survival of human eccrine sweat gland\u2013derived epithelial cells","volume":"132","author":"Czifra","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0034","doi-asserted-by":"crossref","DOI":"10.1080\/19381980.2017.1361576","article-title":"Recent advances in the endocrinology of the sebaceous gland.","volume":"9","author":"Sz\u00f6ll\u0151si","year":"2017","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0035","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/jid.2010.421","article-title":"Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1","volume":"131","author":"T\u00f3th","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0036","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/exd.13042","article-title":"Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry\/seborrhoeic skin and acne treatment","volume":"25","author":"Ol\u00e1h","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0037","first-page":"1389","article-title":"The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content","volume":"28","author":"Ali","year":"2015","journal-title":"Pak J Pharm Sci"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0038","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1096\/fj.07-104877","article-title":"Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling","volume":"22","author":"Dobrosi","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0039","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.beem.2018.02.003","article-title":"Novel mechanisms of G-protein-coupled receptors functions: AT","volume":"32","author":"T\u00f3th","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0040","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1021\/np8002673","article-title":"Antibacterial cannabinoids from Cannabis sativa: a structure-activity study","volume":"71","author":"Appendino","year":"2008","journal-title":"J Nat Prod"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202933","article-title":"The ameliorative effect of hemp seed hexane extracts on the Propionibacterium acnes-induced inflammation and lipogenesis in sebocytes","volume":"13","author":"Jin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0042","unstructured":"ClinicalTrials. Botanix Pharmaceuticals. A randomized, double-blind, vehicle-controlled study to evaluate the safety and efficacy of btx 1503 in patients with moderate to severe acne vulgaris. NCT03573518. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03573518. Accessed March, 2020"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0043","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/15569527.2016.1169541","article-title":"Dermatological aspects of synthetic cannabinoid addiction","volume":"36","author":"Inci","year":"2017","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0044","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000366195","article-title":"Smoking and dietary factors associated with moderate-to-severe acne in French adolescents and young adults: results of a survey using a representative sample","volume":"230","author":"Wolkenstein","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0045","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0002-9440(10)62320-6","article-title":"A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1\/TRPV1) signaling in human hair growth control","volume":"166","author":"Bod\u00f3","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0046","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/jid.2011.122","article-title":"Activation of transient receptor potential vanilloid-3 inhibits human hair growth","volume":"131","author":"Borb\u00edr\u00f3","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0047","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jid.2018.11.020","article-title":"TRPV4 is expressed in human hair follicles and inhibits hair growth in vitro","volume":"139","author":"Szab\u00f3","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0048","doi-asserted-by":"crossref","first-page":"12487","DOI":"10.1523\/JNEUROSCI.3106-06.2006","article-title":"Release probability-dependent scaling of the postsynaptic responses at single hippocampal GABAergic synapses","volume":"26","author":"Bir\u00f3","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0049","first-page":"389","article-title":"The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata","volume":"158","author":"Betz","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0050","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3892\/etm.2015.2728","article-title":"Association between PTPN22 C1858T polymorphism and alopecia areata risk","volume":"10","author":"Salinas-Santander","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0051","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.bmcl.2009.03.046","article-title":"Hair growth stimulator property of thienyl substituted pyrazole carboxamide derivatives as a CB1 receptor antagonist with in vivo antiobesity effect","volume":"19","author":"Srivastava","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0052","series-title":"Conference on Cannabinoids in Medicine (September 17-15th, 2015)","article-title":"The effect of 0.1% cannabidiol ointment for intractable alopecia areata: a clinical case report","author":"Arakaki","year":"2015"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0053","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jaad.2017.02.056","article-title":"The role of cannabinoids in dermatology","volume":"77","author":"Mounessa","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0054","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jaad.2020.01.036","article-title":"Cannabinoids for the treatment of chronic pruritus: a review","volume":"82","author":"Avila","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5021\/ad.2016.28.1.22","article-title":"Selective cannabinoid receptor-1 agonists regulate mast cell activation in an oxazolone-induced atopic dermatitis model","volume":"28","author":"Nam","year":"2016","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0056","first-page":"97","article-title":"Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study","volume":"13","author":"Szepietowski","year":"2005","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0057","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/BJ20041682","article-title":"Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells","volume":"388","author":"Small-Howard","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0058","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2011.11.009","article-title":"Endocannabinoids limit excessive mast cell maturation and activation in human skin","volume":"129","author":"Sugawara","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0059","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.bcp.2010.02.015","article-title":"Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin","volume":"79","author":"Leonti","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00011-003-1162-z","article-title":"Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin","volume":"52","author":"Dvorak","year":"2003","journal-title":"Inflamm Res"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0061","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00213-011-2224-5","article-title":"CB 1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action","volume":"216","author":"Schlosburg","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0062","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/ced.13398","article-title":"Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist","volume":"43","author":"Bilir","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0063","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","article-title":"Cannabinoid ligands targeting TRP channels","volume":"11","author":"Muller","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0064","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/bph.12029","article-title":"Activation and desensitization of TRPV1 channels in sensory neurons by the PPAR\u03b1 agonist palmitoylethanolamide","volume":"168","author":"Ambrosino","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0065","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/jpet.108.150136","article-title":"Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus","volume":"329","author":"Schlosburg","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0066","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.bmcl.2012.02.072","article-title":"Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent","volume":"22","author":"Odan","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0067","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2006.05.040","article-title":"The cannabinoid CB2 receptor inverse agonist JTE-907 suppresses spontaneous itch-associated responses of NC mice, a model of atopic dermatitis","volume":"542","author":"Maekawa","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0068","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-3083.2007.02351.x","article-title":"Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study)","volume":"22","author":"Eberlein","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0069","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00105-006-1180-1","article-title":"Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus [in German]","volume":"57","author":"St\u00e4nder","year":"2006","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0070","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2147\/CIA.S65448","article-title":"N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients","volume":"9","author":"Yuan","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0071","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1572-0241.2002.05852.x","article-title":"Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease","volume":"97","author":"Neff","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0072","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09546630510035832","article-title":"Efficacy of dietary hempseed oil in patients with atopic dermatitis","volume":"16","author":"Callaway","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0073","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tips.2009.05.004","article-title":"The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities","volume":"30","author":"B\u00edr\u00f3","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0074","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/exd.12414","article-title":"Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate-induced mouse atopic-like dermatitis","volume":"23","author":"Gaffal","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0076","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1111\/ijd.12841","article-title":"Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model","volume":"54","author":"Kim","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0077","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1600-0625.2012.01561.x","article-title":"Cannabinoid receptors 1 and 2 oppositely regulate epidermal permeability barrier status and differentiation","volume":"21","author":"Roelandt","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0078","first-page":"208","article-title":"Use of a palmitoylethanolamide containing nonsteroidal cream for treating atopic dermatitis: impact on the duration of response and time between flares","volume":"20","author":"Del Rosso","year":"2007","journal-title":"Cosmetic Dermatology"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0079","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/jpet.117.244368","article-title":"Anti-inflammatory properties of cannabidiol, a nonpsychotropic cannabinoid, in experimental allergic contact dermatitis","volume":"365","author":"Petrosino","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0080","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.1142265","article-title":"Attenuation of allergic contact dermatitis through the endocannabinoid system","volume":"316","author":"Karsak","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0081","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2005.08.013","article-title":"Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice","volume":"520","author":"Ueda","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0082","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/molecules24050918","article-title":"Cannabinoid signaling in the skin: therapeutic potential of the \u201cc(ut)annabinoid\u201d system","volume":"24","author":"T\u00f3th","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0083","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/ard.2010.137539","article-title":"The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model","volume":"70","author":"Balistreri","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0084","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/annrheumdis-2011-200314","article-title":"Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis","volume":"71","author":"Gonzalez","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"suppl 2","key":"10.1016\/j.clindermatol.2021.05.006_bib0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/annrheumdis-2017-eular.2712","article-title":"A phase 2 study of safety and efficacy of anabasum (JBT-101), a cannabinoid receptor type 2 agonist, in diffuse cutaneous systemic sclerosis [abstract]","volume":"76","author":"Spiera","year":"2017","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0086","doi-asserted-by":"crossref","first-page":"e00394","DOI":"10.1002\/prp2.394","article-title":"Ajulemic acid: potential treatment for chronic inflammation","volume":"6","author":"Burstein","year":"2018","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0087","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2353\/ajpath.2010.090763","article-title":"Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis","volume":"177","author":"Servettaz","year":"2010","journal-title":"Am J Pathol"},{"issue":"suppl 10","key":"10.1016\/j.clindermatol.2021.05.006_bib0088","first-page":"763","article-title":"A phase 2 study of safety and efficacy of lenabasum (JBT-101), a cannabinoid receptor type 2 agonist, in refractory skin-predominant dermatomyositis [abstract]","volume":"69","author":"Werth","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0089","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.jid.2017.05.035","article-title":"Cannabinoid reduces inflammatory cytokines, tumor necrosis factor-\u03b1, and type I interferons in dermatomyositis in vitro","volume":"137","author":"Robinson","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0090","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/annrheumdis-2019-eular.7759","article-title":"Lenabasum, a cannabinoid type 2 receptor agonist, reduces CD4 cell populations and downregulates type 1 and 2 interferon activities in lesional dermatomyositis skin [abstract]","volume":"78","author":"Chen","year":"2019","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0091","first-page":"161","article-title":"Design of phase 3 study of lenabasum for the treatment of dermatomyositis","volume":"99","author":"Werth","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0092","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biocel.2018.04.010","article-title":"Endocannabinoid system in systemic lupus erythematosus: first evidence for a deranged 2-arachidonoylglycerol metabolism","volume":"99","author":"Navarini","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"issue":"suppl 10","key":"10.1016\/j.clindermatol.2021.05.006_bib0093","article-title":"Topical endocannabinoid administration protects MRL-Lpr\/Lpr mice from cutaneous lupus erythematosus [abstract]","volume":"70","author":"Chalmers","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0095","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1111\/pde.13545","article-title":"Self-initiated use of topical cannabidiol oil for epidermolysis bullosa","volume":"35","author":"Chelliah","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0096","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/bjd.17619","article-title":"Time to drop the stigma: cannabinoids are drugs that may alleviate pain in people with epidermolysis bullosa","volume":"180","author":"Martinez","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0097","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/bjd.17341","article-title":"Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases","volume":"180","author":"Schr\u00e4der","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0098","series-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","article-title":"Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: an Evidence Review and Research Agenda","year":"2017"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0099","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/clpt.2011.188","article-title":"Cannabinoid-opioid interaction in chronic pain","volume":"90","author":"Abrams","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpain.2012.10.009","article-title":"Low-dose vaporized cannabis significantly improves neuropathic pain","volume":"14","author":"Wilsey","year":"2013","journal-title":"J Pain"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0101","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/j.1532-2149.2012.00242.x","article-title":"Involvement of peripheral cannabinoid and opioid receptors in \u03b2-caryophyllene-induced antinociception","volume":"17","author":"Katsuyama","year":"2013","journal-title":"Eur J Pain"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0102","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0304-3959(03)00068-X","article-title":"Topical cannabinoid antinociception: synergy with spinal sites","volume":"105","author":"Dogrul","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0103","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(03)00245-8","article-title":"Topical cannabinoid enhances topical morphine antinociception","volume":"105","author":"Yesilyurt","year":"2003","journal-title":"Pain"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2021.05.006_bib0104","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.21037\/apm.2017.08.05","article-title":"A selective review of medical cannabis in cancer pain management","volume":"6","author":"Blake","year":"2017","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0105","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jpain.2015.07.009","article-title":"Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient data","volume":"16","author":"Andreae","year":"2015","journal-title":"J Pain"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0106","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/1756-185X.13146","article-title":"Endocannabinoids in arthritis: current views and perspective","volume":"20","author":"Barrie","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0107","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3949\/ccjm.85a.17115","article-title":"Cannabis for peripheral neuropathy: the good, the bad, and the unknown","volume":"85","author":"Modesto-Lowe","year":"2018","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0108","first-page":"88","article-title":"Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia","volume":"8","author":"Phan","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0109","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jpainsymman.2017.06.005","article-title":"Topical medical cannabis: a new treatment for wound pain\u2014Three cases of pyoderma gangrenosum","volume":"54","author":"Maida","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12950-018-0201-z","article-title":"Cannabinoid 2 receptor attenuates inflammation during skin wound healing by inhibiting M1 macrophages rather than activating M2 macrophages","volume":"15","author":"Du","year":"2018","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0111","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2016.06.006","article-title":"Pharmacological activation of cannabinoid 2 receptor attenuates inflammation, fibrogenesis, and promotes re-epithelialization during skin wound healing","volume":"786","author":"Wang","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.07.009","article-title":"Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1\u207b\/\u207b mice","volume":"33","author":"Bilkei-Gorzo","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0113","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2478\/s11658-012-0023-6","article-title":"Cannabinoid-like anti-inflammatory compounds from flax fiber","volume":"17","author":"Styrczewska","year":"2012","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0114","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/862391","article-title":"Flax fiber hydrophobic extract inhibits human skin cells inflammation and causes remodeling of extracellular matrix and wound closure activation","volume":"2015","author":"Styrczewska","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/1874473710666170712113042","article-title":"Cannabis: an overview of its adverse acute and chronic effects and its implications","volume":"10","author":"Ford","year":"2017","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0116","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/phar.1187","article-title":"The pharmacologic and clinical effects of medical cannabis","volume":"33","author":"Borgelt","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0117","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/17425255.2020.1754793","article-title":"Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials","volume":"16","author":"Dos Santos","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0118","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1096\/fj.06-7689com","article-title":"Inhibition of human hair follicle growth by endo- and exocannabinoids","volume":"21","author":"Telek","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0119","first-page":"8803","article-title":"Ultra-structural hair alterations of drug abusers: a scanning electron microscopic investigation","volume":"8","author":"Turkmenoglu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0120","first-page":"19","article-title":"Review of the effects of Cannabis smoking on oral health","volume":"42","author":"Darling","year":"1992","journal-title":"Int Dent J"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0121","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0528.1993.tb00725.x","article-title":"Effects of Cannabis smoking on oral soft tissues","volume":"21","author":"Darling","year":"1993","journal-title":"Community Dent Oral Epidemiol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0122","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-0714.1990.tb00852.x","article-title":"Effect of Cannabis use on oral candidal carriage","volume":"19","author":"Darling","year":"1990","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0123","first-page":"189","article-title":"Cannabis abuse and oral health care: review and suggestions for management","volume":"58","author":"Darling","year":"2003","journal-title":"SADJ"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0124","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0964-1955(97)00022-5","article-title":"Marijuana use and oral cancer: a review","volume":"33","author":"Firth","year":"1997","journal-title":"Oral Oncol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0125","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1017\/S002221510011429X","article-title":"Marijuana smoking as a possible cause of tongue carcinoma in young patients","volume":"104","author":"Almadori","year":"1990","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0126","first-page":"1","article-title":"The therapeutic potential of cannabinoids in dermatology","volume":"23","author":"Marks","year":"2018","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0127","first-page":"1071","article-title":"Marijuana use and increased risk of squamous cell carcinoma of the head and neck","volume":"8","author":"Zhang","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0128","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.otohns.2007.12.002","article-title":"Cannabis use and cancer of the head and neck: case-control study","volume":"138","author":"Aldington","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0129","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1158\/0008-5472.CAN-03-3425","article-title":"Marijuana use and risk of oral squamous cell carcinoma","volume":"64","author":"Rosenblatt","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1158\/1055-9965.EPI-13-0181","article-title":"Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium","volume":"23","author":"Marks","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0131","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.avsg.2013.01.002","article-title":"Cannabis-associated arterial disease","volume":"27","author":"Desbois","year":"2013","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000331970105200101","article-title":"Cannabis arteritis revisited\u2014Ten new case reports","volume":"52","author":"Disdier","year":"2001","journal-title":"Angiology"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0133","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1468-3083.2006.01947.x","article-title":"Cannabis arteritis: a new case report and a review of literature","volume":"21","author":"Peyrot","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5 Suppl 1","key":"10.1016\/j.clindermatol.2021.05.006_bib0134","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaad.2007.04.024","article-title":"Cannabis arteritis","volume":"58","author":"No\u00ebl","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0135","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/000331970105200711","article-title":"Regarding \u201cCannabis arteritis revisited\u2014Ten new case reports","volume":"52","author":"No\u00ebl","year":"2001","journal-title":"Angiology"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0136","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.0105-1873.2006.0560h.x","article-title":"Contact urticaria to Cannabis sativa","volume":"54","author":"Majmudar","year":"2006","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0137","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1610-0387.2007.06270.x","article-title":"Generalized pruritus in a patient sensitized to tobacco and cannabis","volume":"5","author":"St\u00f6ckli","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0138","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-0536.2007.01169.x","article-title":"Work-related contact urticaria to Cannabis sativa","volume":"58","author":"Williams","year":"2008","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0139","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.aller.2010.09.008","article-title":"Allergic hypersensitivity to Cannabis in patients with allergy and illicit drug users","volume":"39","author":"Armentia","year":"2011","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/1203475417738971","article-title":"The risks and benefits of Cannabis in the dermatology clinic","volume":"22","author":"Dhadwal","year":"2018","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0141","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-75-4-571","article-title":"Allergy to marihuana","volume":"75","author":"Liskow","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0142","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaip.2016.10.019","article-title":"Where there's smoke, there's fire: Cannabis allergy through passive exposure","volume":"5","author":"Decuyper","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0143","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/cea.12177","article-title":"Allergy to illicit drugs and narcotics","volume":"44","author":"Swerts","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0144","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.anai.2012.01.008","article-title":"Hypersensitivity reactions to marijuana","volume":"108","author":"Tessmer","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000346721","article-title":"New food allergies in a European non-Mediterranean region: is Cannabis sativa to blame?","volume":"161","author":"Ebo","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0146","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/archderm.143.3.430","article-title":"Acute generalized exanthematous pustulosis caused by illicit street drugs?","volume":"143","author":"Lu","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0147","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jaad.2019.03.015","article-title":"Allergenic ingredients in commercial topical cannabinoid preparations","volume":"81","author":"Adler","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0148","first-page":"50","article-title":"Topical cannabinoids in dermatology","volume":"100","author":"Hashim","year":"2017","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0149","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clindermatol.2018.11.002","article-title":"The growing trend of cannabidiol in skincare products","volume":"37","author":"Jhawar","year":"2019","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.006_bib0150","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03093402, 2017. [Accessed 9 March 2020]"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21000705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21000705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:21:15Z","timestamp":1760034075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X21000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":149,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0738081X21000705"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.05.006","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabis and the skin","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}